These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1723816)

  • 1. Experimental evaluation of heparin-coated cardiopulmonary bypass equipment with low systemic heparinization and high-dose aprotinin.
    von Segesser LK; Weiss BM; Pasic M; Leskosek B; von Felten A; Pei P; Turina M
    Thorac Cardiovasc Surg; 1991 Oct; 39(5):251-6. PubMed ID: 1723816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
    von Segesser LK; Garcia E; Turina MI
    Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
    von Segesser LK; Turina M
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction and elimination of systemic heparinization during cardiopulmonary bypass.
    von Segesser LK; Weiss BM; Garcia E; von Felten A; Turina MI
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):790-8; discussion 798-9. PubMed ID: 1548923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization.
    von Segesser LK; Weiss BM; Garcia E; Gallino A; Turina M
    Eur J Cardiothorac Surg; 1990; 4(12):639-43. PubMed ID: 2288743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term cardiopulmonary bypass without systemic heparinization.
    von Segesser K; Turina M
    Int J Artif Organs; 1990 Oct; 13(10):687-91. PubMed ID: 2254046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular assist with heparin surface coated devices.
    von Segesser LK; Weiss BM; Bisang B; Leskosek B; Turina MI
    ASAIO Trans; 1991; 37(3):M278-9. PubMed ID: 1751148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system, endothelial damage, and cytokine release in patients with cardiac operation employing aprotinin and steroids.
    Inui K; Shimazaki Y; Watanabe T; Takahashi T; Minowa T; Takeda H; Yanagawa N; Sotoda Y
    Artif Organs; 1999 Dec; 23(12):1107-12. PubMed ID: 10619929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin.
    Kipfer B; Englberger L; Gygax E; Nydegger U; Carrel T
    Transfus Apher Sci; 2003 Aug; 29(1):17-24. PubMed ID: 12877888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reheparinisation requirements after cardiopulmonary bypass in patients treated with aprotinin.
    Bailey CR; Fisher AR; Wielogorski AK
    Br Heart J; 1994 Nov; 72(5):442-5. PubMed ID: 7529520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiopulmonary bypass over 24 hours without systemic anticoagulation: new horizons?].
    von Segesser LK; Turina M
    Helv Chir Acta; 1990 Oct; 57(2):389-93. PubMed ID: 2074206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of heparin-coated perfusion equipment with special emphasis on patients refusing homologous transfusions.
    von Segesser LK; Weiss BM; Garcia E; Turina MI
    Perfusion; 1991; 6(3):227-33. PubMed ID: 10171161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management.
    Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery.
    Najman DM; Walenga JM; Fareed J; Pifarré R
    Ann Thorac Surg; 1993 Mar; 55(3):662-6. PubMed ID: 7680854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept.
    Ranucci M; Pazzaglia A; Isgrò G; Cazzaniga A; Ditta A; Boncilli A; Cotza M; Carboni G; Brozzi S; Bonifazi C
    Int J Artif Organs; 2002 Sep; 25(9):875-81. PubMed ID: 12403404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin surface coated hard shell venous reservoirs: experimental evaluation ex vivo.
    von Segesser LK; Mihaljevic T; Tönz M; Leskosek B; Pei P; Turina M
    Int J Artif Organs; 1994 Dec; 17(12):651-6. PubMed ID: 7759145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.